Daniel J. Gerritzen serves as Executive Vice President Legal, General Counsel, and Secretary at OrthoPediatrics Corp, a publicly traded medical device company dedicated to advancing treatments for pediatric orthopedic conditions. In this multifaceted role, he oversees all legal, compliance, regulatory, and corporate secretarial functions, providing strategic counsel to the executive team and Board of Directors. His responsibilities include managing mergers and acquisitions, intellectual property protection, risk mitigation, and ensuring adherence to FDA regulations and global standards, enabling the company's innovation-driven growth in serving children worldwide. With over 20 years of experience in the medical device and healthcare industries, Gerritzen joined OrthoPediatrics in 2020 from Amedica Corporation, where he served as General Counsel and led legal strategies during a pivotal restructuring and product commercialization phase. Previously, he held senior positions at Zimmer Biomet Holdings, Inc., including Associate General Counsel, where he managed complex litigation, international contracts, and compliance programs across a multibillion-dollar enterprise. His career also includes roles at Eli Lilly and Company, honing his expertise in pharmaceutical and device law. Gerritzen's achievements include guiding OrthoPediatrics through significant acquisitions, such as the 2021 purchase of Pega Medical, which expanded its portfolio of specialized implants, and supporting seamless SEC compliance amid rapid revenue growth. A graduate of Indiana University Maurer School of Law (J.D.) and Indiana University (B.A.), he is recognized for his proactive approach to ethical governance and has been instrumental in positioning OrthoPediatrics as a leader in pediatric orthopedics.